Prescription medication · Nasal Corticosteroid
ciclesonide nasal
Also sold as Omnaris, Zetonna. This medicine treats nasal symptoms from seasonal allergies in adults and kids 6 years and older.
Data updated 2026-05-15
- 3
- InteractionsFew interactions
- $22.60
- Brand price (NADAC)
ciclesonide nasal (Omnaris) is a prescription Nasal Corticosteroid. This medicine treats nasal symptoms from seasonal allergies in adults and kids 6 years and older.
Omnaris Nasal Spray is a medicine that helps treat allergy symptoms in your nose. It contains a steroid that reduces inflammation.
Verify with FDA → · CMS NADAC pricing →
Drug Pricing (NADAC)
Brand Price
$22.60/unit
Generic Available
No
Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →
What it does
This medicine treats nasal symptoms from seasonal allergies in adults and kids 6 years and older.
Common side effects
Headache, Nosebleeds, Nasal passage inflammation
Key warnings
This medicine may cause nosebleeds or a Candida (fungal) infection in your nose.
The sections below are summarized in plain English from ciclesonide nasal's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Omnaris contains ciclesonide, a type of steroid. It works by reducing inflammation in your nose. This helps to relieve allergy symptoms like stuffiness and runny nose.
Serious Warnings
This medicine may cause nosebleeds or a Candida (fungal) infection in your nose. It can also cause a hole in the wall between your nostrils, and slow wound healing in your nose. Tell your doctor if you have vision changes or a history of glaucoma or cataracts. This medicine may also hide symptoms of an infection, worsen existing infections, or slow growth in children.
Known Drug Interactions
In a drug interaction study, co-administration of orally inhaled ciclesonide and oral ketoconazole, a potent inhibitor of cytochrome P450 3A4, increased the exposure (AUC) of des-ciclesonide by approximately 3.6-fold at steady state, while levels of ciclesonide remained unchanged.
Mechanism: Ketoconazole slows down the process of clearing the active medicine from your system. This results in much higher levels of the drug in your body.
Erythromycin, a moderate inhibitor of cytochrome P450 3A4, had no effect on the pharmacokinetics of either des-ciclesonide or erythromycin following oral inhalation of ciclesonide [see Clinical Pharmacology ( 12.3 )] .
Mechanism: Studies show that erythromycin does not change the amount of medicine that stays in your body.
7 DRUG INTERACTIONS In vitro studies and clinical pharmacology studies suggested that des-ciclesonide has no potential for metabolic drug interactions or protein binding-based drug interactions [see Clinical Pharmacology ( 12.3 )] . In a drug interaction study, co-administration of orally inhaled ciclesonide and oral ketoconazole, a potent inhibitor of cytochrome P450 3A4, increased the exposure (AUC) of des-ciclesonide by approximately 3.6-fold at steady state, while levels of ciclesonide remained unchanged. Erythromycin, a moderate inhibitor of cytochrome P450 3A4, had no effect on the...
Mechanism: This drug does not seem to change how other medicines are broken down or carried in the blood.
This is a plain-language summary of FDA-label interaction records and does not provide individual medication-combination directions.
Common Questions
What should I do if I get a nosebleed?
Can this medicine cause infections?
How long can I use this nasal spray?
Can this medicine affect my vision?
Can children use this medicine?
What if I have a cold?
Can I use this after nasal surgery?
What does 'prime the pump' mean?
Can I use this if I'm allergic to other nasal sprays?
Does this interact with other medications?
What are the common side effects of ciclesonide nasal?
Does ciclesonide nasal interact with other medications?
What drug class is ciclesonide nasal?
What pregnancy or breastfeeding source fields are listed for ciclesonide nasal?
Related Medications in Nasal Corticosteroid
Other drugs grouped near ciclesonide nasal - same-class peers and common alternatives.
azelastine
Astelin, Astepro
Azelastine nasal spray is an antihistamine medicine.
Compare with ciclesonide nasal →
budesonide nasal
Rhinocort
Rhinocort is a nasal spray that helps relieve allergy symptoms.
Compare with ciclesonide nasal →
cetirizine
Zyrtec
Cetirizine (Zyrtec) is an antihistamine medicine.
Compare with ciclesonide nasal →
chlorpheniramine
Chlor-Trimeton
Chlorpheniramine is an antihistamine medicine.
Compare with ciclesonide nasal →
desloratadine
Clarinex
Desloratadine is an antihistamine medicine.
Compare with ciclesonide nasal →
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
FDA bioequivalence and label-record context for narrow therapeutic index medicines
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Save on ciclesonide nasal
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for ciclesonide nasal
The FDA label for ciclesonide nasal (sold under brand names such as Omnaris, Zetonna) classifies it as a prescription-only medication in the Nasal Corticosteroid class. This medicine treats nasal symptoms from seasonal allergies in adults and kids 6 years and older. Official labeling lists 5 commonly reported side effects, including Headache, Nosebleeds, Nasal passage inflammation.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. Voluntary reports accumulate over the lifetime of a drug and reflect wide-ranging clinical use. The database also lists 3 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated minor severity. NADAC pricing from CMS.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.
Last updated: November 8, 2022
PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages